> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA FY 21 Budget Initiatives Analyzed
- URL: https://www.fdaweb.com/fda-fy-21-budget-initiatives-analyzed/
- Published: 2020-11-13T12:00:00.000Z
- Updated: 2026-09-14T16:36:18.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5148088

The Alliance for a Stronger FDA says the president’s FY 21 budget request for FDA, the House-passed bill, and the Senate’s new proposed bill have similar funding levels and a common core of initiatives for the agency to carry out in the new fiscal year if, as the Alliance expects, FDA receives about a $40 million increase for FY 21\. The Alliance [says](https://strengthenfda.org/2020/11/13/where-40-million-might-go-for-fy-21/?ref=fdaweb.com) these six programs are most likely to receive the funding: 

- artificial intelligence and other emerging technologies (food safety and medical devices);
- strengthening response capabilities for foodborne outbreaks;
- cannabis and cannabis derivatives;
- modernizing influenza vaccines;
- transforming medical device safety, cybersecurity, review, and innovation; and
- compounding.

The current FY 21 continuing resolution runs through 12/11, the statement says. The Alliance expects that either action on funding bills will be completed by that date, another short-term continuing resolution will be passed to give more time to finish the FY 21 package, or a longer-term continuing resolution will be adopted to move the process to early next year.